trimetazidine has been researched along with kainic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carricondo, F; Gil-Loyzaga, P; Hernández, E; Poch-Broto, J; Simón, F | 1 |
| Bonne, C; D'Aldin, C; Maurin, L; Muller, A; Payet, O | 1 |
2 other study(ies) available for trimetazidine and kainic acid
| Article | Year |
|---|---|
Trimetazidine prevents cochlear lesions induced by intraperitoneal and perilymphatic administration of kainic acid.
Topics: Animals; Electrophysiology; Excitatory Amino Acid Agonists; Injections, Intralymphatic; Injections, Intraperitoneal; Kainic Acid; Male; Microscopy, Electron; Nerve Degeneration; Neurotoxins; Organ of Corti; Rats; Rats, Long-Evans; Reaction Time; Trimetazidine; Vasodilator Agents; Vestibulocochlear Nerve | 1999 |
Anti-excitotoxic activity of trimetazidine in the retina.
Topics: Administration, Oral; Animals; Cell Line; Disease Models, Animal; Electroretinography; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Guinea Pigs; Ischemia; Kainic Acid; Rats; Rats, Wistar; Retina; Retinal Diseases; Trimetazidine | 2004 |